Cabergoline Tablets IP 1 mg are specialized pharmaceutical formulations designed specifically for the effective management of various gynecological conditions. Manufactured under stringent WHO-GMP compliant processes by IndiGlobal Exports, these tablets adhere to Indian Pharmacopoeia (IP) standards, ensuring superior quality, precise dosage, and consistent therapeutic outcomes. Ideal for international pharmaceutical markets, these tablets come in export-grade blister or strip packaging, making them suitable for bulk distribution and institutional use. The product supports clinical treatment regimens within hospital and retail pharmacy settings, delivering reliable efficacy for healthcare providers managing gynecologic disorders. Each tablet contains 1 mg of cabergoline, a potent dopaminergic agent used to treat conditions related to hyperprolactinemia and other endocrinological gynecology indications, ensuring both safety and compliance with global healthcare regulations.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Cabergoline 1 mg per tablet |
| Indication | Management of gynecological conditions |
| Manufacturing Standards | WHO-GMP compliant facilities |
| Quality Compliance | Indian Pharmacopoeia (IP) standards |
| Packaging | Export-grade blister or strip packs |
| Therapeutic Use | Treats hyperprolactinemia and related gynecology conditions |
| Dosage Form | Tablet |
| Suitable Markets | International pharmaceutical export markets |
| Manufacturer | IndiGlobal Exports |
| Shelf Life | As per regulatory standards |
| Attributes | Description |
|---|---|
| Dosage Strength | 1 mg |
| Formulation Type | Tablet |
| Pharmacopoeial Compliance | Indian Pharmacopoeia (IP) |
| Packaging Format | Blister or strip pack |
| Therapeutic Category | Gynecology |
| Production Facility | GMP-compliant manufacturing sites |
| Intended Use | Clinical treatment of gynecological endocrine disorders |
| Export Quality | Certified for international markets |
| Manufacturer | IndiGlobal Exports |
| Shelf Life | Complies with regulatory requirements |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Cabergoline Tablets IP 1 mg are primarily used in the management of gynecological endocrine disorders, particularly hyperprolactinemia-related conditions such as prolactinomas, amenorrhea, and infertility caused by elevated prolactin levels.
Yes, these tablets are manufactured following WHO-GMP guidelines and Indian Pharmacopoeia standards, ensuring compliance with international pharmaceutical regulations, making them suitable for export to regulated and semi-regulated markets.
The product is available in export-grade blister or strip packaging designed for bulk distribution and institutional supply, ensuring product integrity during transportation and storage.
Each batch is produced in GMP-compliant facilities with rigorous quality control protocols and pharmacopoeial testing to maintain precise dosage accuracy and consistent therapeutic performance.
These tablets comply with Indian Pharmacopoeia (IP) standards and are produced in WHO-GMP certified plants, meeting regulatory benchmarks required for pharmaceutical exports.
Brand: indiglobal exports
Country Of Origin: India
Cabergoline Tablets IP 1 mg is a pharmaceutical product indicated for gynecology treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Cabergoline Tablets IP 1 mg is developed for the effective management of gynecology conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with gynecology indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
